A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Explore 11592 conditions in our directory, and growing.
Condition name for this article.

Autoimmune hemolytic anemia

Other Names: AIHA, Immunohemolytic anemia, Autoimmune haemolytic anaemia, Immunohaemolytic anaemia.
Causes Symptoms Treatment Prognosis Lifestyle FAQ

At a Glance

Autoimmune hemolytic anemia is a rare immune disorder where the body produces antibodies that destroy its own red blood cells faster than they can be replaced, leading to a shortage of oxygen-carrying cells.
This rare condition can affect people of all ages but is most commonly diagnosed in middle-aged and older adults, while specific subtypes like paroxysmal cold hemoglobinuria are more frequently seen in children.
The condition can present as a sudden acute episode or a long-term chronic illness, but it is generally treatable and manageable with appropriate medical care.
While the outlook is generally positive with treatment, the condition often requires ongoing management to prevent relapse and carries risks of complications like blood clots that can impact long-term health.

See Your Ranked Personalized Treatments

A graphic depicting a sample medication report that registered members can run.
Impact in entire body.

How It Affects You

Autoimmune hemolytic anemia is a condition where the immune system mistakenly targets and destroys the body's own red blood cells, which are responsible for carrying oxygen to tissues. This rapid destruction, known as hemolysis, forces the bone marrow to work overtime and often places stress on the spleen and liver as they filter out damaged cells. The resulting shortage of healthy red blood cells leads to widespread effects throughout the body.

  • Reduced oxygen supply causes generalized fatigue, weakness, and shortness of breath.
  • The breakdown of blood cells releases substances that can turn the skin and eyes yellow (jaundice) and darken the urine.
  • The heart may beat faster or irregularly as it attempts to compensate for the lower oxygen levels in the blood.

.

Causes and Risk Factors

Underlying Biological Mechanisms
In autoimmune hemolytic anemia, the immune system malfunctions and produces proteins called antibodies that attach to red blood cells. These antibodies signal the body's defense system, specifically the spleen or liver, to destroy these cells as if they were foreign invaders. The destruction happens faster than the bone marrow can produce new cells to replace them. This process is broadly categorized by the temperature at which the antibodies react: warm antibody hemolytic anemia involves antibodies that are active at body temperature, while cold antibody hemolytic anemia involves those active at colder temperatures.

Triggers and Risk Factors
In about half of all cases, the cause is unknown, which is referred to as idiopathic. In other cases, the condition is secondary to other health issues. Known triggers and risk factors include:

  • Autoimmune disorders such as lupus or rheumatoid arthritis.
  • Cancers of the blood or lymphatic system, such as chronic lymphocytic leukemia and non-Hodgkin lymphoma.
  • Viral infections, including mononucleosis (Epstein-Barr virus), mycoplasma pneumonia, and viral infections in children.
  • Certain medications, such as specific antibiotics or blood pressure drugs, which can trigger an immune reaction.
  • Prior history of blood or marrow transplants.

Prevention Strategies
There is no known way to prevent the onset of primary autoimmune hemolytic anemia because the cause of the immune malfunction is often unknown. For secondary cases, managing the underlying condition or stopping a triggering medication may help control the disease. For individuals with cold antibody types, avoiding exposure to cold temperatures is a key preventive strategy to stop the destruction of red blood cells and reduce flare-ups.

A graphic depicting a sample medication report that registered members can run.
.

Diagnosis, Signs, and Symptoms

Clinically Meaningful Symptoms
Symptoms develop because the body tissues are not receiving enough oxygen. The onset can be sudden or gradual. Common signs include extreme tiredness, weakness, and pale skin. As red blood cells break down, they release pigments that cause yellowing of the skin and whites of the eyes (jaundice) and turn urine a dark, tea-like color. Patients may also experience shortness of breath, dizziness, and a rapid or irregular heartbeat. In cold-reactive types, people may notice their hands and feet turning blue or feeling painful when exposed to cold temperatures.

Diagnostic Tests and Exams
Clinicians diagnose the condition using blood tests that evaluate the number and health of blood cells. Key tests include:

  • Complete Blood Count (CBC) to check for low hemoglobin levels.
  • Reticulocyte count to see if the bone marrow is producing new red blood cells rapidly to replace lost ones.
  • Peripheral blood smear to look for abnormally shaped red blood cells under a microscope.
  • Direct Antiglobulin Test (Coombs test), which determines if antibodies are stuck to the surface of red blood cells; this is the primary tool for confirming the diagnosis and determining the subtype.
  • Bilirubin and haptoglobin tests to confirm that red blood cell destruction (hemolysis) is occurring.

Differential Diagnosis
Doctors must rule out other causes of anemia, such as iron deficiency, hereditary blood disorders like sickle cell disease, or other non-immune causes of hemolysis.

.

Treatment and Management

Medications and Therapies
Treatment depends on whether the anemia is caused by warm or cold antibodies. For warm antibody autoimmune hemolytic anemia, corticosteroids are typically the first line of defense to suppress the immune system and stop the attack. If steroids are ineffective, doctors may prescribe other medications that target immune cells, such as rituximab. For cold antibody types, steroids are generally not effective; treatment often involves keeping warm and using specific therapies like rituximab or newer drugs that inhibit the immune system's complement pathway.

Procedures and Surgical Options
If medications do not control the condition, surgical removal of the spleen (splenectomy) may be recommended, particularly for warm antibody types, as the spleen is a primary site where red blood cells are destroyed. In severe, life-threatening emergencies, blood transfusions may be necessary, although finding compatible blood can be difficult due to the antibodies present.

Lifestyle and Monitoring
Patients with cold agglutinin disease must protect themselves from cold weather to prevent symptom flares. All patients require regular monitoring of blood counts to check for relapse. Because the condition involves the immune system, patients should discuss vaccination schedules with their provider to prevent infections, especially if the spleen is removed or immune-suppressing drugs are used.

When to Seek Medical Care
It is important to contact a healthcare provider if symptoms of anemia return or worsen. Seek immediate medical attention if you experience:

  • Chest pain or severe shortness of breath.
  • Sudden, severe weakness or fainting.
  • Noticeable yellowing of the skin or eyes.
  • Dark or bloody urine.
  • Signs of a blood clot, such as swelling and pain in one leg.

A graphic depicting a sample medication report that registered members can run.
.

Severity and Prognosis

Disease Course and Severity
The severity of autoimmune hemolytic anemia varies widely. Some individuals have mild anemia that requires no treatment, while others experience rapid, life-threatening destruction of blood cells. The course can be temporary, especially in children recovering from a virus, or chronic, requiring long-term management. Relapses are common, meaning the condition can return after a period of improvement.

Complications and Risks
The most significant risk associated with this condition is the formation of blood clots (thrombosis), particularly in the veins of the legs or lungs, which can be dangerous. Other complications include increased susceptibility to infections due to immune-suppressing treatments or spleen removal. Severe anemia can also strain the heart, potentially leading to heart failure in vulnerable individuals.

Prognosis and Life Expectancy
With modern treatment, the prognosis is generally good, and most people manage the condition well. Survival rates are high, particularly for younger patients and those with primary (idiopathic) disease. However, the outlook can be more serious for older adults or those with underlying cancers or severe cardiovascular issues. Early diagnosis and appropriate management of blood clot risks significantly improve outcomes.

.

Impact on Daily Life

Managing Daily Activities
Fatigue is the most common complaint and can impact work, school, and social activities. Patients may need to pace themselves and prioritize rest during flare-ups. Moderate exercise is generally encouraged when stable, but strenuous activity may be difficult during periods of active anemia. For those with cold sensitivity, wearing warm clothing, gloves, and hats is a practical necessity during cooler months.

Emotional and Mental Health
Living with a chronic and unpredictable condition can be stressful. The fear of relapse or the side effects of medications like steroids (which can affect mood and sleep) may impact emotional well-being. Connecting with support groups or seeking counseling can help manage the emotional burden of chronic illness.

Questions to Ask Your Healthcare Provider
Patients can better manage their health by asking targeted questions during appointments:

  • Is my condition primary, or is it caused by another underlying disease?
  • Which type of antibodies do I have (warm or cold), and how does that change my treatment?
  • What are the side effects of the medications you are prescribing?
  • How often do I need blood tests to monitor my condition?
  • What specific signs should prompt me to call you immediately?
  • Do I need to take special precautions regarding vaccinations or infections?

A graphic depicting a sample medication report that registered members can run.
.

Common Questions and Answers

Q: Is autoimmune hemolytic anemia a form of cancer?
A: No, it is not cancer. However, it can sometimes occur as a secondary condition in people who have certain blood cancers, such as chronic lymphocytic leukemia or lymphoma.

Q: Can this condition be cured?
A: In some cases, especially those triggered by an infection or medication, the condition can go away completely once the trigger is removed. For chronic cases, there is often no permanent cure, but treatment can induce long periods of remission where no symptoms are present.

Q: Is it safe to exercise with this condition?
A: Generally, yes, but you should listen to your body. During an active flare-up when red blood cell counts are low, you may need to limit physical exertion to avoid straining your heart.

Q: Do I need a special diet?
A: There is no specific diet that cures the condition, but eating a balanced diet rich in folic acid helps support the bone marrow as it works to produce new red blood cells.

Q: Is autoimmune hemolytic anemia hereditary?
A: It is generally not considered a hereditary condition and is not passed directly from parents to children, although a family history of autoimmune diseases can slightly increase the risk.

Content last updated on February 12, 2026. Always consult a qualified health professional before making any treatment decisions or taking any medications. Review our Terms of Service for full details.